Rodríguez-Perea et al.'s study has shown that statins use could significantly increase the number of CD4(+)FOXP3(+) regulatory T cells in healthy persons even in the absence of infections, which might increase immunity (Rodriguez-Perea et al., 2015). This evidence concerns the gene FOXP3 and infection.